日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Survival after pathological complete response following neoadjuvant chemotherapy versus chemoradiotherapy for oesophageal squamous cell carcinoma

食管鳞状细胞癌新辅助化疗与放化疗后病理完全缓解后的生存率比较

Okui, Jun; Matsuda, Satoru; Nagashima, Kengo; Sato, Yasunori; Kawakubo, Hirofumi; Ruhstaller, Thomas; Thuss-Patience, Peter; Nilsson, Magnus; Klevebro, Fredrik; Tan, Lijie; Zhang, Shaoyuan; Aparicio, Thomas; Piessen, Guillaume; van der Zijden, Charlène; Mostert, Bianca; Wijnhoven, Bas P L; Tsushima, Takahiro; Takeuchi, Hiroya; Kato, Ken; Kitagawa, Yuko

Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trials

根治性食管切除术后条件性无复发生存率:11项试验的个体患者数据分析

Okui, Jun; Matsuda, Satoru; Nagashima, Kengo; Sato, Yasunori; Kawakubo, Hirofumi; Ruhstaller, Thomas; Thuss-Patience, Peter; Nilsson, Magnus; Klevebro, Fredrik; Tan, Lijie; Zhang, Shaoyuan; Aparicio, Thomas; Piessen, Guillaume; van der Zijden, Charlène; Mostert, Bianca; Wijnhoven, Bas P L; Tsushima, Takahiro; Takeuchi, Hiroya; Kato, Ken; Kitagawa, Yuko

Perioperative nivolumab and chemotherapy in locally advanced squamous cell carcinoma of the oesophagus: a randomized multicentre phase 2 study with circulating tumor DNA dynamics monitoring

围手术期纳武利尤单抗联合化疗治疗局部晚期食管鳞状细胞癌:一项采用循环肿瘤DNA动态监测的随机多中心II期研究

Jiao, Heng; Lin, Siyun; Gu, Jianmin; Jiang, Dongxian; Cui, Peng; Huang, Zhiliang; Fang, Yong; Wang, Hao; Lin, Miao; Tang, Han; Jiang, Tian; Lin, Guangyi; Zhang, Shaoyuan; Yin, Hao; Liang, Fei; Wang, Jingshu; Fan, Xuning; Qiu, Fujun; Yang, Yang; Li, Zhigang; Li, Bin; Xiang, Jiaqing; Leng, Xuefeng; Han, Yongtao; Li, Chengcheng; Ai, Luoyan; Hou, Yingyong; Wang, Guoqiang; Zhang, Zhihong; Cai, Shangli; Liu, Tianshu; Yin, Jun; Tan, Lijie

Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trials

评估病理完全缓解作为可切除食管癌总生存期的替代终点:对 III 期试验中个体患者数据的综合分析

Okui, Jun; Nagashima, Kengo; Matsuda, Satoru; Sato, Yasunori; Kawakubo, Hirofumi; Ruhstaller, Thomas; Thuss-Patience, Peter; Nilsson, Magnus; Klevebro, Fredrik; Tan, Lijie; Zhang, Shaoyuan; Aparicio, Thomas; Piessen, Guillaume; van der Zijden, Charlène; Mostert, Bianca; Wijnhoven, Bas P L; Tsushima, Takahiro; Takeuchi, Hiroya; Kato, Ken; Kitagawa, Yuko

Integrating crop models, single nucleotide polymorphism, and climatic indices to develop genotype-environment interaction model: A case study on rice flowering time

整合作物模型、单核苷酸多态性和气候指数构建基因型-环境互作模型:以水稻开花期为例

Zhang, Jinhan; Zhang, Shaoyuan; Yang, Yubin; Yan, Wenliang; Lin, Xiaomao; Wilson, Lloyd T; Liu, Bing; Liu, Leilei; Xiao, Liujun; Zhu, Yan; Cao, Weixing; Tang, Liang

Identification and validation of poor prognosis immunoevasive subtype of esophageal cancer with tumor-infiltrating SAMD3 + NK cell abundance.

鉴定和验证肿瘤浸润 SAMD3+NK 细胞丰度高的预后不良的免疫逃逸型食管癌亚型

Huang Xu, You Runze, Liu Fangyi, Jian Zitao, Zhou Guanyou, Yin Hao, Wu Mengyuan, Sun Tiantao, Duan Zhiyun, Xu Wenyi, Zhang Shaoyuan, Yang Xinyu, Jiao Heng, Yang Shuyi, Wang Qingle, Yin Jun, Tang Han, Lin Miao, Tan Lijie

Electroacupuncture regulates gut microbiota to reduce depressive-like behavior in rats

电针调节肠道菌群以减少大鼠的抑郁样行为

Junying Wang, Haohan Zhu, Xingke Song, Jun Zhao, Jianliang Zhang, Jinling Zhang, Shaoyuan Li, Peijing Rong

Publisher Correction: Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

出版商更正:新辅助阿德布雷利单抗治疗局部晚期可切除食管鳞状细胞癌:一项 1b 期试验

Yin, Jun; Yuan, Jingnan; Li, Yunjin; Fang, Yong; Wang, Ruoxi; Jiao, Heng; Tang, Han; Zhang, Shaoyuan; Lin, Siyun; Su, Feng; Gu, Jianmin; Jiang, Tian; Lin, Dong; Huang, Zhiliang; Du, Chaoxiang; Wu, Kui; Tan, Lijie; Zhou, Qing

Cellular Localization of FOXO3 Determines Its Role in Cataractogenesis

FOXO3 的细胞定位决定了其在白内障形成中的作用

Xiaoqi Li, Yingxin Qu, Qinghua Yang, Runpu Li, Yumei Diao, Junyi Wang, Lingling Wu, Chuyue Zhang, Shaoyuan Cui, Limin Qin, Deyi Zhuo, Huiyi Wang, Liqiang Wang, Yifei Huang

Neoadjuvant therapy with immunoagent (nivolumab) or placebo plus chemotherapy followed by surgery and adjuvant treatment in subjects with resectable esophageal squamous cell carcinoma: study protocol of a randomized, multicenter, double blind, phase II trial (NATION-2203 trial)

免疫药物(纳武利尤单抗)或安慰剂联合化疗的新辅助治疗,随后进行手术和辅助治疗,用于可切除的食管鳞状细胞癌患者:一项随机、多中心、双盲 II 期试验的研究方案(NATION-2203 试验)

Yin, Jun; Lin, Siyun; Fang, Yong; Jiao, Heng; Chen, Zongwei; Tang, Han; Gu, Jianmin; Zhang, Shaoyuan; Sun, Linyi; Li, Yin; Han, Yongtao; Chen, Qixun; Chen, Haiquan; Li, Zhigang; Tan, Lijie